Abstract
The zebrafish (Danio rerio) is emerging as a new important species for studying mechanisms of brain function and dysfunction. Focusing on selected central nervous system (CNS) disorders (brain cancer, epilepsy, and anxiety) and using them as examples, we discuss the value of zebrafish models in translational neuroscience. We further evaluate the contribution of zebrafish to neuroimaging, circuit level, and drug discovery research. Outlining the role of zebrafish in modeling a wide range of human brain disorders, we also summarize recent applications and existing challenges in this field. Finally, we emphasize the potential of zebrafish models in behavioral phenomics and high-throughput genetic/small molecule screening, which is critical for CNS drug discovery and identifying novel candidate genes.
Keywords: brain disorders, anxiety, epilepsy, cancer, zebrafish, biomarkers
The developing utility of zebrafish in neuroscience research
Native to Southeast Asia, the zebrafish (Danio rerio) has become a popular model organism in biomedical research (Figure 1). Multiple advantages of using this species in biomedicine include high physiological and genetic homology to mammals, external fertilization, rapid development, transparency of embryos and larvae, ease of genetic and other experimental manipulations, as well as cost- and space-effectiveness [1–6]. Detailed analyses of the strengths and limitations of zebrafish models in biomedical research and their relevance to neuroscience have been provided in recent literature [7–13], and are briefly summarized in Table 1 (also see Glossary).
Table 1.
Model advantages |
An in vivo model and a vertebrate species with common conserved cell types, organs, and physiological systems (e.g., stress endocrine axis, Figure 1C) |
Sufficient physiological complexity and high physiological homology to humans |
High genetic homology to humans; genetically tractable organism with fully sequenced genome |
Ease of genetic manipulation and the availability of a wide range of genetic tools for the zebrafish (see Glossary) |
Quick and abundant reproduction (e.g., a single female lays several hundred eggs each week) |
Rapid development (hatching in <3 days and becoming mature by day 90); helpful for studying neurodevelopmental disorders. Development from ‘transparent’ eggs; transparent embryos (enables monitoring organ development and manipulating it in vivo – e.g., by injecting drugs or genes) |
External development (zebrafish can be exposed to various environmental factors neonatally outside of the maternal organism, in a more experimentally controllable environment) |
High space/cost-efficiency and excellent potential for high-throughput screens |
Availability of various zebrafish strains, with over 1000 transgenic and mutant zebrafish strains |
Adherence, as a lower vertebrate, to the 3R principles (replacement, refinement, reduction) |
Smaller brains (which can be better assessed using the newest imaging techniques), see text and Figure 2 for details |
Model limitations |
Duplication of genome (some zebrafish genes have two copies instead of one, as in mammals) |
Not as many well-characterized inbred strains as mice have (note that zebrafish, and fish in general, unlike rodents, do not tolerate inbreeding and rapidly lose fertility with inbreeding) |
Drugs which are not water-soluble can be problematic to administer by water immersion (but the use of solvents as well as other routes are available) |
Species differences in blood–brain barrier (BBB). Although zebrafish develop the BBB similar to that of humans, species differences exist and may affect permeability for certain drugs |
Some complex behaviors develop over time (e.g., social behaviors are not prominent in larval fish) |
Parental care is not known (although key for modeling some developmental disorders, such as autism, and may require alternative species to be used) |
Certain brain areas are not as developed as in mammals (e.g., cortex), and some CNS structures in zebrafish are still difficult to map to their mammalian counterparts (this knowledge gap may complicate the interpretation of circuitry–behavior interplay) |
Together with mammals and popular invertebrate model species (Figure 1), both larval and adult zebrafish are extensively used in central nervous system (CNS) research [14–16] and targeting various brain disorders (Figures 2–4, Table 2). However, the lack of prior experience with zebrafish models and phenotypes among various non-fish neuroscience laboratories hinders the wider application of this aquatic species in brain research (see Table S1 in the supplementary material online and [13] for details). Recognizing the potential of the zebrafish for translational neuroscience [7,9,14,17–20], we discuss the growing role of this organism in studying brain pathogenesis and its experimental modulation.
Table 2.
Test | Zebrafish phenotypes | Relevance to | Refs | |
---|---|---|---|---|
Clinical anxiety | Rodent models | |||
Novel tank test | Characteristic diving behavior, thigmotaxis (peripheral swimming), reduction of exploration (especially in the top part of novel tanks, Figure 4B), increased erratic behavior and freezing/ immobility, elevated whole body cortisol and brain c-fos (these responses are highly sensitive to anxiolytic and anxiogenic agents) | GAD, AP | Novelty-based (open field, elevated plus maze) tests | [4,20,95–100] |
Light–dark box | Avoidance of ‘white’ arenas (scototaxis), reduced exploration, and fewer visits to the white, elevated whole body cortisol and brain c-fos (these responses are highly sensitive to anxiolytic and anxiogenic agents)c | GAD, PD | Light–dark box | [74,96,101] |
Predator fish exposure | Characteristic diving following acute exposure of predator fish, increased erratic behavior and freezing, elevated whole body cortisol and brain c-fos (Figure 1C), as well as increased escape behavior (increased distance from the stressor, Figure 4C). In group-tested fish, also induces characteristic shoal tightening (Figure 4C)d | SP, PD (PTSDb) | Predator (cat, fox, snake) exposure paradigm | [102,103] |
Robotic ‘predator fish’ exposure | Aversive responses in a preference test and in traditional anxiety/ fear-related tests (e.g., light–dark box). These responses are reduced by conventional anxiolytic drugs (e.g., ethanol) | SP, PD (PTSDb) | ? | [104] |
Animated bird silhouette presentation | The model uses exposure to an animated (moving) image of a bird silhouette, decreasing the distance of the zebrafish from the bottom of the tank and increasing erratic movements. Anxiolytic treatments (e.g., ethanol) dose-dependently attenuate these responses | SP, PD (PTSDb) | Predator image exposure test | [105] |
Beaker stress | Elevated whole body cortisol and other anxiety-like behaviors following exposure to a beaker (novelty stress, social isolation stress) | GAD, PD | Social isolation stress, novelty-based tests | [13] |
Alarm pheromone exposure | Characteristic diving behavior, reduced exploration, increased erratic behavior and freezing, elevated whole body cortisol, and brain c-fos expression. Recent studies implicate the medial habenula and interpeduncular nucleus in mediating these responses. | SP, PD | Predator (cat, fox) odor exposure paradigm | [97,106] |
Shoaling test | Acute stress (novelty, predator, or alarm pheromone exposure) evokes overt changes in zebrafish shoals, including tightening the shoals (Figure 4C), as well as increased thigmotaxis and bottom dwelling. | GAD, SAD (PTSDb) | Mouse social behavior test | [57] |
Pharmacogenic anxiety | Characteristic diving behavior, increased thigmotaxis, reduced exploration (e.g., in the novel tank or the light–dark box), increased erratic behavior and freezing, as well as elevated whole body cortisol and brain c-fos following exposure to anxiogenic drugs (e.g., pentylenetetrazole or caffeine). | GAD, SMA | Pharmacogenic anxiety | [51] |
Other drug-related anxiety (withdrawal) | Characteristic diving behavior, increased thigmotaxis, reduced exploration in novelty tests, increased erratic behavior and freezing, as well as elevated whole body cortisol and brain c-fos following single or repeated withdrawal from selected drugs (alcohol, benzodiazepines, barbiturates, opioids, or psychostimulants) | GAD, SMA | Withdrawal- evoked anxiety | [6,107] |
Genetic models of anxiety: various wild type strains | The availability of several strains of zebrafish [e.g., leopard strain or wild Indian karyotype (WIK), derived from wild caught Indian zebrafish] as well as wild caught zebrafish (e.g., caught in the wild in India) which display high baseline anxiety (compared with less anxious zebrafish strains, such as AB or Tu strains) | GAD | High-anxiety mouse and rat strains | [7,108] |
Mutant zebrafish models | Mutant strains (e.g., glucocorticoid receptor knockout zebrafish) showing elevated cortisol with increased anxiety-like behaviors (elevated freezing, reduced exploration) in novelty tests | GAD, comorbidity with depression | Mutant rodents with high- anxiety phenotypese | [24,25] |
Transgenic models | Anxiogenic stimuli (e.g., alarm pheromone or overhead moving shadow) evoke heightened anxiety responses in transgenic zebrafish with medial habenular silenced by tetanus toxin | GAD, PD (PTSDb) | Transgenic rodents with high-anxiety phenotypes | [75] |
Optogenetic models | Optogenetically mediated ‘hypercortisolic’ zebrafish, displaying stress-like cortisol and behavioral (hyperlocomotor) responses | GAD (PTSDb) | Elevated cortisol and stress behavior | [39] |
Startle test | The startle response is the instinctive reaction of zebrafish to novel unexpected and/or aversive stimuli (e.g., bright light, tapping/ vibration, or loud sound). Anxiogenic factors typically potentiate, and anxiolytic factors reduce, startle responses in zebrafish (similar to their effects in rodents and humans) | GAD, PD (PTSDb) | Startle test | [19] |
Sleep deprivation | Sleep-deprived fish display increased anxiety-like behavior (e.g., increased preference for dark in the light–dark box) | GAD | Sleep deprivation | [23] |
Acute restraint stress (ARS) | Increased anxiety-like behavior (similar to rodent responses) following acute (e.g., 90-min) ARS | PD, SP | ARS | [109] |
Unpredictable chronic stress (UCS) | Increased anxiety-like behaviors and CRH expression (paralleling rodent responses) following the UCS protocol (e.g., applied for 7 or 14 days) | GAD (PTSDb) | UCS | [93] |
Major anxiety spectrum disorders include separation anxiety (SA), specific phobias (SP), social anxiety disorder (SAD), panic disorder (PD), agoraphobia (AP), generalized anxiety disorder (GAD), substance/medication-induced anxiety (SMA) [83].
These zebrafish models may also be relevant to post-traumatic stress disorder (PTSD), which, albeit recognized as a separate disorder from the anxiety spectrum [83], shares many symptoms and is frequently comorbid with anxiety disorders.
Neuronal activity mapping using c-fos reveals the engagement of the medial zone of the dorsal telencephalic region and the dorsal nucleus of the ventral telencephalic area (the teleost anatomical homologs of the mammalian amygdala and striatum) [74].
Similar anxiety-like responses can be elicited with an image presentation of the predator on a computer screen [20,103].
For example, highly ‘anxious’ serotonin transporter (SERT) knockout mice and rats [110].
Because of the general scope of this review, here we highlight only certain areas and applications of zebrafish models, using them as representative examples. Specifically, we emphasize methodological benefits of zebrafish for brain imaging, behavioral phenomics and high-throughput screening (HTS), critical for CNS drug discovery and identifying novel candidate genes for brain disorders [7]. We also focus on selected brain disorders, chosen based on their pathogenetic nature, ranging from neoplastic to neurological and neuropsychiatric illnesses (Figure 3A). However, it is important to understand that zebrafish brain studies are much broader, covering a wide spectrum of CNS disorders and conditions that can be targeted using zebrafish (Table S2 in the supplementary material online) [7,13]. For example, marked progress has recently been made developing zebrafish models relevant to autism, sleep disorders, cognitive deficits, depression, psychoses, and addiction [5,9,21–29]. Taken together, mounting evidence indicates that the zebrafish is rapidly becoming one of the main organisms in translational neuroscience and biopsychiatry research, successfully complementing both rodent and clinical models of almost every major brain disorder [7,9,13,30].
Zebrafish CNS imaging
Developing novel biomarkers of brain disorders benefits from neuromorphological studies using animal models, including zebrafish. Zebrafish offer several important advantages in this regard (Table 1). For example, larval zebrafish are highly transparent [8] and permit an unprecedented optical access to their CNS. This feature is valuable for in vivo neuronal network analysis and recently developed whole brain/single cell functional imaging techniques that enable monitoring of neuronal activity in hundreds of neurons at once [31,32]. The adult zebrafish brain is relatively small, but shares many organizational features with its mammalian counterpart [7]. Although adult zebrafish are not transparent (but see [33,34]), they are also useful to study normal brain and identify anomalies associated with its pathology.
A series of experimental techniques described here can be used for economical, rapid, and high-resolution neuromorphological analyses of the zebrafish brain (Figure 2). For example, the small zebrafish brain is ideal for 3D reconstruction of individual regions or whole brains using conventional magnetic resonance imaging (MRI; Figure 2A) [35]. This method has an isotropic resolution of 10 mm in an ex vivo zebrafish brain, representing the highest resolution achieved in a vertebrate brain, also comparable in slice thickness to conventional histology [35]. This allows fine details, such as fiber tracts (e.g., fasciculus retroflexus) or even some cellular layers (e.g., stratum marginale in the tectum), to be revealed [35]. Thus, this resolution is sufficient for imaging regions and their substructures in the zebrafish brain, and can be used to assess both the CNS morphological abnormalities (e.g., occurring as a result of a disease) and the gross morphology of various brain regions and their connectivity.
More detailed analyses of zebrafish brain structures can be conducted using simple whole mount histochemistry and widely available laser scanning microscopy. This approach enables an in-depth anatomical mapping of intact brain regions [e.g., olfactory bulb (OB) and telencephalon (TEL) in Figure 2B] and the pathways that connect them, without having to section and digitally reconstruct tissue samples. Figure 2B shows an example of a whole mounted zebrafish brain, where the stained inputs and partial outputs of the OB (green) are imaged and overlaid with information on the locations of axonal terminals (red). The small brain size in zebrafish enables staining and mounting the whole intact tissue sample while also permitting adequate staining and imaging of the regions that comprise this tissue (see [36] for details). As illustrated in Figure 2B, this approach permits accurate imaging and reconstruction of connectivity between brain regions (see, e.g., a small axon bundle that connects OB and TEL, readily visible in a whole mounted brain). By contrast, if the same tissue was to be sectioned, this connection may not be immediately apparent, and would have to await laborious manual and digital reconstruction of the sectioned material in order to be revealed.
Extension of this analysis may also include the use of histochemical markers for certain neurotransmitters (i.e., serotonin and dopamine, known to be involved in affective or neurological disorders). Such markers have already been tested in zebrafish [37], are commercially available, and enable systems level neurotransmitter analyses with mapping normal and abnormal connectivity phenotypes in fish.
In addition to assessing regional (Figure 2A) and interregional (Figure 2B) CNS connectivity, it is also possible to use the intact zebrafish brain for substructural imaging, again without requiring to section the tissue. Consider, for example, an optical cross-section of the zebrafish optic tectum, the region that receives retinal input (green; Figure 2C). To examine cell types involved in modulating this input, counterstaining can be performed with an antibody that detects specific (e.g., cholinergic) neurons (red; Figure 2C). Imaging this brain with a confocal microscope can generate high-resolution images, clearly revealing the anatomical relationships between these two neuronal systems in the intact brain.
Furthermore, neuromorphological analyses in zebrafish can also utilize traditional Golgi impregnation techniques. Serving neuroscience research for more than a century, this method enables high-resolution microscopic visualization of neuronal somata and dendritic arbors (where most of the neuronal volume is located) [38]. Applied to zebrafish recently, Golgi staining shows that fish neuronal ultrastructure is indeed very similar to that of rodents [7]. Because dendritic spines receive the vast majority of excitatory input to neurons, the assessment of dendritic branching and spines reflects the health of the neurons and the integrity of the circuitry in a specific brain region [38].
Finally, the increasing availability of the newest sophisticated optical imaging systems [39] markedly advances zebrafish CNS research. Although in vivo optophysiological analyses of neuronal network function [40–43] have mainly been established in larval zebrafish, they can also be applied to adult fish (e.g., in the casper zebrafish strain [33,34], which retains high transparency into adulthood, thus permitting optical access to the CNS even in adults). Recently developed methods for clearing brain tissue (e.g., SeeDB [44] and CLARITY [45]) may further enhance zebrafish neuroimaging. Although originally developed in rodents (e.g., [45]), such methods can be particularly useful for zebrafish CNS analyses. Other important recent developments include tracking of single presynaptic and postsynaptic structures (e.g., using genetically encoded calcium indicators, GECIs) in zebrafish [46,47], representing powerful tools for ‘systems neuroscience’ studies using this organism. Collectively, these experimental approaches can produce comprehensive and powerful neuromorphological datasets to help identify disease biomarkers in the zebrafish, complementing its in-depth behavioral and physiological analyses.
Automated behavioral analyses
Behavioral phenotypes are the most complex product of CNS activity, and the availability of reliable video tracking techniques markedly empowers neurobehavioral analyses in zebrafish [27,48]. For example, both commercial and custom-made video tracking systems are used to assess larval and adult zebrafish behavior. Such automated observations are particularly suitable for measuring locomotor responses (e.g., distance traveled or speed/velocity, turning, etc.) that human observers cannot quantify [12]. Examples of commercially available software packages for zebrafish research include Ethovision developed by Noldus IT (Netherlands), LocoScan created by CleverSys, Inc. (USA), or ZebraLab produced by ViewPoint (France). Such software systems often have modular structure and are standardized, user-friendly, and coupled with thoughtfully designed hardware. Although not inexpensive, these packages are also validated by multiple international users, and typically come with regular upgrades and technical support, which becomes especially useful from a practical point of view. Offering a free alternative, the custom-made tracking systems are also available from different laboratories worldwide (e.g., [49]) and can be useful for various specific neurophenotyping tasks and experimental set-ups in zebrafish.
Applications of automated video tracking tools to behavioral research in larval and adult zebrafish are illustrated in Figure 4, showing robust anxiety-like or anxiolytic-like responses detected and quantified by the software (see in-depth discussion further). For larval models, the most common endpoints are locomotory, such as distance traveled and immobility/freezing (Figure 4A), which may often decrease or increase with anxiety, respectively [12,19]. Adult zebrafish behavior (Figure 4B) is much more complex and includes multiple parameters, often with complex spatial components (see Table 2 and [6,19,50,51] for details). Some other brain disorders, such as autism (a severely debilitating developmental disorder affecting 1–2% of the global population [52,53]), can also be modeled using zebrafish [7]. The use of zebrafish to target social deficits is based on rich social behaviors in this species [7]. For example, zebrafish prefer to swim in shoals (Figure 4C), and the disruption of this group-forming behavior by various environmental, pharmacological, or genetic factors can be easily assessed [14,17,54]. Fully automated video tracking tools can ‘extract’ zebrafish social phenotypic data by monitoring several fish in parallel [48] and analyzing the proximity of three pairs of their body points relative to each other (see Figure 4D for details). With the growing application of cross-species behavioral analyses (e.g., using behavioral activity monitors to directly compare aberrant behaviors in human patients and rodent tests [55,56]), the inclusion of zebrafish in such translational neuropsychiatric studies can be particularly useful.
Another important aspect of computer-based behavioral analysis in zebrafish is their locomotion in 3D (swimming in XYZ coordinates) [50]. This situation markedly differs from typical rodent tests, which are mainly based on animal activity in a horizontal 2D plane (Figure 4B). The value of an additional (vertical) dimension is particularly important for zebrafish models, as their robust diving response to anxiogenic stimuli (Figure 4B) represents a natural zebrafish ‘survival’ behavior in the wild, and remains highly sensitive in laboratory zebrafish. A two-camera experimental set-up (e.g., as in Figure 4B) allows automated 3D neurophenotyping of zebrafish locomotion in XYZ coordinates by taking images from top and side views, and integrating them using various software packages into 3D signals. The ability to visualize and quantify behaviors in 3D enhances neurophenotyping using zebrafish and reveals high sensitivity of their 3D track reconstructions to various experimental manipulations (Figure 4B, see [50] for conceptual rationale and validation). For instance, 3D reconstructions of zebrafish swim patterns not only show high sensitivity to a wide array of pharmacological manipulations [5,6,50] but also extend the range of measurable indices (e.g., loops, tight circles, ‘slide-and-fall’ or ‘figure-8’ patterns). Many of them can be sensitive to specific drug classes (e.g., serotonergic vs glutamatergic agents) or behavioral profiles (e.g., withdrawal anxiety states, psychological anxiety states, fear/panic-like states, or neurological/motor deficits) [50]. Furthermore, whereas 3D-based analysis is currently applied to adult zebrafish [50,57], its high potential for drug discovery may eventually lead to 3D analysis of larval behavior, markedly enhancing their traditional ‘2D’ HTS (Figure 4A).
Behavioral phenomics
Recent progress in bioinformatics has led to a new field of neuroscience – behavioral phenomics, that links complex behavioral phenotypes to various genetic mutations and environmental manipulations [58]. Phenotyping of various mutant and transgenic zebrafish [59–61] becomes important for neurogenetics and pharmacology, and such HTS are widely used for screening genetic mutations and small molecules, as part of behavioral phenomics approaches. Because zebrafish possess ‘evolutionarily conserved’ neuromediator systems with high homology to rodents and humans [7,37], the translational value of these screens is clear. Moreover, zebrafish are sensitive to all major classes of neurotropic drugs (including antipsychotics, mood stabilizers, anxiolytics, antidepressants, ethanol, sedatives, stimulants, hallucinogens, antiepileptics, anesthetic/analgesics, and cognitive enhancers) [7]. Taken together, this demonstrates the value of zebrafish for modeling complex drug-evoked phenomena, eventually leading to new effective therapies for major groups of brain disorders [7]. Given the potential to screen hundreds of compounds per day, zebrafish HTS are critical for rapidly identifying active compounds or candidate genes to address these needs [10,12].
The possibility to develop 3D-based HTS for larval and adult zebrafish is important both practically and conceptually, because it can take zebrafish behavioral phenomics in a new direction. For example, in vivo HTS are based on the balance between the number of compounds to test and the number of endpoints to assess (Figure 4A). As already mentioned, typical HTS in zebrafish currently test multiple compounds in sensitive/fast 2D assays and focus on selected well-established, but relatively simple, behavioral endpoints (e.g., time spent moving, velocity, distance traveled, or heading) [10,59,62]. Thus, the breadth of testing in such HTS is typically preferred over the depth of phenotypic analyses. Similar to other species, zebrafish HTS are extensive, but limited in the ability to ‘dig deeper’ and extract rich behavioral information from a larger number of endpoints and their patterns. Therefore, we argue that the use of automated 3D-based behavioral analyses in zebrafish [50], combined with IT-based ‘behavior recognition’ of individual movement patterns (e.g., circling, loops, social heading), may enable zebrafish HTS to maintain their extensive nature, yet analyzing in-depth multiple novel endpoints and motor patterns.
Furthermore, despite general agreement among zebrafish scientists that a key advantage of zebrafish is the cost-effective HTS, how to perform such screens for behavioral phenotypes is less clear. Because behavioral phenotyping is a complex task, even for the mouse (the most frequently employed model organism of biomedical research), the organization of phenotyping screens is actively debated in the field [63–65]. Most agree that a single behavioral test is not enough to characterize an animal phenotype, and therefore test batteries must be used [63,66]. One way to organize a test battery is to move from least stressful/invasive tests to most invasive tests, thereby reducing the chance that behavioral responses are affected by prior test history [66,67]. Test batteries can also be organized in a ‘bottom up’ manner, that is, with the simpler behavioral functions tested first, and then gradually increasing the complexity of behavioral screening. The advantage of this strategy is in its systematic and logical, step-by-step analysis of a large number of behaviors. An alternative ‘top down’ strategy can also be efficient because starting analyses with the most complex behavior (e.g., memory) enables detecting all alterations that influence performance in the task designed to quantify the behavior (i.e., some associated with memory, others with simpler motor characteristics). This approach allows investigators to quickly identify mutants or drugs that did not alter the phenotype of interest and perform follow-up analyses on those animals that did show phenotypical modifications.
Another related, actively debated problem is standardization of neurophenotyping tests [68–70]. For example, although standardization is critical for consistency and cross-laboratory comparability of HTS, the new mutations or drugs may have unique effects on brain function and behavior, thereby necessitating custom-tailored paradigms and analyses. Thus, the best strategy can be a compromise – to use standardized HTS, followed up by secondary tests (custom-tailored to the functional abnormality detected). Although discussed in depth in rodent literature ([63,64,71], Box 1) little is known about behavioral test batteries for zebrafish. Nevertheless, with the increasing number of zebrafish behavioral studies utilizing newly developed test paradigms (Table 2) and the technical advancements in movement monitoring, quantification, and analyses (see above), it is likely that neurophenotype-based HTS will be routinely employed in zebrafish. Coupled with sophisticated forward- and reverse-genetic methods (Glossary) developed for the zebrafish, these behavioral screens may provide an unprecedented coverage of critical genetic and biological mechanisms, underlying even the most complex behavioral functions or disorders of the vertebrate brain.
Box 1. Outstanding questions.
This section highlights selected outstanding questions and problems associated with the application of zebrafish models in neuroscience research (also see [7,13] for detailed discussion).
Applying optimal test batteries
Test batteries are a series of specific behavioral paradigms, clustered by category/domain (e.g., cognitive, feeding, pain, social, anxiety, depression, psychoses, reward), and are commonly used in neurobehavioral analyses, especially in rodents [64,67,114]. Test batteries depend on specific needs and research questions, but typically consist of well-characterized paradigms from the established neurobehavioral literature [67]. Combining individual tests in ‘smart’ (‘hybrid’) batteries has also been suggested to maximize the number of phenotypes assessed per trial [115]. Overall, test batteries are practical, time/cost-efficient, and valid, because they help dissociate simple performance characteristics (e.g., motor function, perception, attention, and motivation) from more complex behavioral traits, including learning, memory or anxiety [66]. In rodents, some (but not all) behavioral tests are sensitive to previous testing experience (test battery effect) [66]. Although many approaches similar to rodent models (Table 2) are used in zebrafish neurophenotyping when designing the aquatic test batteries [27], the effects of test battery on zebrafish behavior have not yet been studied and merit further scrutiny.
Exploring behavioral sex differences
Although far less studied (compared with rodents [64,67,114]), zebrafish display sex differences in behavioral and physiological responses. For example, female zebrafish display higher (than males) dopamine levels in the forebrain and lower 5-hydroxyindolacetic acid/serotonin ratios [116]. Similarly, in the cocaine withdrawal model, females exhibit earlier onset of behavioral withdrawal symptoms than male fish (who show more robust anxiogenic-like withdrawal phenotypes [22]). Given well-known sex differences in human behaviors, the effects of sex on zebrafish phenotypes in various behavioral models necessitate further experimentation (e.g., see recent data on sex and age differences in zebrafish locomotion [117]).
Understanding stress-related neuroendocrine responses
Zebrafish stress responses show striking similarity to human stress, employing cortisol as the major glucocorticoid hormone [39] (Figure 1C). Moreover, individual variation in zebrafish stress responses (similar to the coping styles in other vertebrate species) correlates strongly with basal cortisol levels and its recovery over time [118]. Given the absence of aldosterone production in zebrafish, cortisol may also function as a mineralocorticoid hormone, thereby acting physiologically at both glucocorticoid (GR) and mineralocorticoid (MR) receptors [119]. The exact contribution of these receptors in zebrafish phenotypes remains unclear [119], including their role in CNS-related responses. Although both GR and MR are implicated in medicating various zebrafish responses [16,24,25,119], their signaling pathways should be investigated further, especially in relation to stress, coping, and related neuroendocrine abnormalities.
Developing zebrafish web resources and neuro-ontologies
Currently available zebrafish online resources include multiple outstanding public access biomedical databases available to zebrafish investigators, including the Zebrafish Information Network (ZFIN, the zebrafish model organism database, www.ZFIN.org), the Zebrafish Genome (ENSEMBL) database (www.ensembl.org/index.html), the Zebrafish International Resource Center (ZIRC, www.zebrafish.org), the Zebrafish Neurophenome Project (ZNP, www.kaluefflab.com/znpindex.html), and the Zebrafish Brain Atlas (www.zebrafishbrain.org) [13,19]. Zebrafish research will markedly benefit from developing further databases dedicated to CNS phenotypes and disease models using this and related (e.g., medaka) organisms. In addition, zebrafish neurobehavioral ontology does not currently exist and also needs to be developed to be integrated into the existing animal behavioral ontologies [19].
Dissecting zebrafish neural circuits
Neural circuits potently modulate human and animal behaviors [40,44,72], and various mental disorders are increasingly recognized as ‘circuit disorders’ due to abnormal brain connectivity [73] (Figure 3A). Can zebrafish be used to address this important aspect of CNS pathogenesis, and to dissect brain circuits and their contribution to complex behaviors? Recent experimental evidence strongly supports this notion, as region-specific analyses of the expression of proto-oncogenes can enable mapping brain activity to distinct circuits implicated in specific zebrafish behavior. For example, using in situ hybridization, c-fos expression links zebrafish anxiety-like behavior to habenula- related circuitry, including dorsal and ventral telencephalic areas (the zebrafish homologs of mammalian amygdala and striatum, critical for rodent anxiety behavior) [74]. Consistent with this, anxiogenic stimuli (e.g., alarm pheromone or overhead moving shadow) evoke heightened anxiety responses in transgenic zebrafish with their medial habenular silenced by tetanus toxin [75].
Likewise, learned aversive behavior can be assessed in zebrafish by conditioning their behaviors (e.g., using a red light) and measuring them following an aversive unconditioned stimulus (e.g., electric shock) [76]. In this model, genetic inactivation of the lateral subnucleus of dorsal habenula evokes freezing (versus the normal flight response), suggesting the zebrafish ‘anxiety’ circuit involving the lateral habenula and dorsal interpeduncular nucleus [76]. Although future studies will further dissect zebrafish neural circuits, these examples show how different approaches can already be successfully applied to develop valid zebrafish circuitry-oriented models of complex affective behaviors. Given the evolutionarily conserved nature of anxiety circuits [72] and the ‘circuitry nature’ of various mental disorders [73], such studies can be particularly important for translational neuroscience and biological psychiatry.
Selected applications of zebrafish models to disease modeling
As already mentioned, we specifically focus on several brain disorders, selected among common neoplastic, neurological, and neuropsychiatric illnesses (Figure 3A). Although brain cancer, epilepsy, and anxiety are only some of many examples of using zebrafish to study CNS disorders, they emphasize the translational value of this model organism for neuroscience research [7], also illustrating the breadth of spectrum of brain disorders which can be modeled using zebrafish.
Zebrafish models of brain cancers
Mounting evidence indicates the utility of zebrafish in cancer research, including studying metastatic potential, tumor-induced angiogenesis, extravasation, and tumorigenicity of various cancer lines under different conditions [8,77,78]. Zebrafish also appear to be useful for modeling aggressive ‘killer cancers’, such as glioblastoma, neuroblastoma, and melanoma (Figure 2D) [79–81]. Brain cancers affect a significant portion of the global population, with over 23 000 new cases and 14 000 deaths in 2013 in the USA alone (http://www.cancer.gov/). In children, neuroblastoma is the second most common type of brain tumor (and is also the most common extracranial solid pediatric tumor, often arising in adrenal or ganglion tissues along the spine). Adult zebrafish are a promising model for pediatric neoplasia of the brain and eye (Figure 2D) because, unlike mammals, they retain abundant embryonal neuroepithelium surrounding the ventricles of the brain, and also retain more pluripotent tissue in the eye and optic nerve. Although the CNS is the most common site for solid tumors in children, pediatric brain neoplasia is often less aggressive and can be more successfully treated than tumors in adults. Interestingly, fish species (including zebrafish) are highly resistant to spontaneous gliomas, for reasons not yet understood. However, available transgenic tumor models (Figure 2D) clearly demonstrate that zebrafish readily develop even the most aggressive forms of glioma or glioblastoma multiforme in the eye and brain, if selected genes are perturbed [80]. Early life stage exposure of zebrafish to a variety of carcinogens readily induces brain neuroblastoma, as well as nerve sheath neoplasia of the eye, skull, and other sites. Certain mutant lines of zebrafish develop neurogenic neoplasia fairly rapidly following carcinogen treatment [79]. Early life exposure of zebrafish to carcinogens and utilizing transgenic zebrafish models enables studying a wide variety of epithelial, mesenchymal, neural, and neural crest neoplasms (including some types of cancer, such as chordomas and esthesioneuroblastomas, that rarely occur in other species) [79]. Finally, given robust CNS cancer phenotypes observed in zebrafish models (e.g., Figure 2D), they may not only increase our understanding of tumor pathways, progression, and metastasis but can also be useful for developing new anticancer therapies, the need for which is currently widely recognized in the field, especially for treating aggressive brain tumors.
Zebrafish models of epilepsy
As CNS tumors represent neoplastic disorders associated with tissue damage, neurological disorders (including epilepsy, selected here as an example) are characterized by both brain tissue damage and pathological neural activity (Figure 3A). Epilepsy is a complex neurological disorder which affects ~70 million people worldwide, and has multiple underlying genetic and environmental causes with unclear pathophysiological mechanisms [3]. Commonly studied in rodents, epilepsy can also be modeled in zebrafish. For example, seizure-like behavioral and physiological responses are caused in zebrafish by various experimental manipulations [3,59,82]. Electroencephalographic (EEG) responses, a hallmark of epilepsy, can be recorded in both larval and adult zebrafish [59], to complement hyperactivity and other seizure-like behaviors, such as tremor, spasms, as well as corkscrew and circular swimming (Figure 3B,C), typically not observed in normal fish [3,19,82]. Increased brain expression of early protooncogenes, such as c-fos, is another marker of neuronal activation and is typically elevated during seizures in both rodent models and zebrafish [3,19,82] (Figure 3C).
Moreover, zebrafish are sensitive to drugs and genetic mutations known to cause epilepsy in humans and rodents (e.g., [3,59]), which can help model various neurochemical and genetic aspects of epilepsy. One example of such models is the mind-bomb mutant zebrafish, which displays disturbed E3 ubiquitin ligase activity and Notch signaling, resulting in defects of brain development and in spontaneous seizures [60,61]. Analyzing agar-immobilized larvae, these studies have revealed seizure-like EEG activity and aberrant motor responses in mutant zebrafish, accompanied by altered expression of selected CNS genes [61]. Another example is zebrafish Nav1.1 mutants with the genetically disrupted scn1Lab gene (which normally encodes a voltage-gated sodium channel) [59]. In humans, mutations in SCN1A cause characteristic Dravet syndrome with severe intellectual disability, impaired social development, and drug-resistant seizures [59]. Paralleling clinical findings, scn1Lab mutant zebrafish display a similar neurological phenotype, including spontaneous seizure-like EEG activity, hyperactivity, and convulsions [59]. Supporting the use of zebrafish for modeling pediatric epilepsy (and monogenic epilepsy disorders in general), these mutants are also sensitive to various clinically used antiepileptic treatments (e.g., ketogenic diet, diazepam, valproate, potassium bromide, stiripentol, and clemizole) [59].
Finally, zebrafish represent powerful HTS for testing various proepileptic and antiepileptic drugs [3,59], which becomes particularly evident for screening novel anticonvulsant drugs. This typically includes exposure of many groups of experimental and control animals to a standard proepileptic agent, and identifying groups more resistant to evoked seizure-related physiological and behavioral symptoms [3]. For zebrafish, simultaneous exposure of multiple cohorts/tanks (containing hundreds of fish preexposed to different putative therapeutic agents) in the aquatic system with running convulsant-containing water offers unparalleled time/space and cost efficiency, compared with any rodent studies of a similar design [3]. Recently developed devices for automated drug delivery and medium change in multi-well screening panels (e.g., www.noldus.nl) can help develop further powerful epilepsy- related HTS using larval zebrafish.
Zebrafish models of anxiety spectrum disorders
In addition to neoplastic and neurological disorders discussed earlier, zebrafish are emerging as a promising model to study complex neuropsychiatric illnesses (Figure 4) [4,7,13]. For example, anxiety disorders (including generalized anxiety and other anxiety spectrum disorders, see Table S2 in the supplementary material online and [83]) are among the most common human neuropsychiatric conditions [84–86]. The increasing prevalence and emerging clinical complexity of anxiety disorders necessitates novel therapeutic approaches [84–86] and new experimental models to develop such treatments [87]. One key strategy is to increase the range of model species to enable cross-species analyses of ‘conserved’ affective phenotypes [71,87]. Decades ago, most scientists would be surprised if one suggested seemingly ‘primitive’ fish as a model to study complex affective disorders [13]. However, the situation has dramatically changed recently, as the field now recognizes that zebrafish ‘emotional’ behavior is complex and highly sensitive to various environmental manipulations [19]. Zebrafish also possess significant genetic, endocrine, and anatomical homology with humans and rodents in relation to anxiety traits. For instance, adult and larval zebrafish express well-developed endocrine ‘stress’ axis [88,89] (Figure 1C) and robust anxiety-like responses (Table 1 and Figure 4B). In line with this, zebrafish are bidirectionally sensitive to a wide range of anxiogenic and anxiolytic drugs, generally paralleling rodent and clinical data for these agents [7].
Larval and adult zebrafish anxiety-related behaviors have already been discussed above (also see [19] for a comprehensive catalog). Table 2 summarizes currently available experimental models of zebrafish anxiety-like behavior and their striking similarity to rodent paradigms. For example, increased emotional reactivity is a core symptom of clinical anxiety and has long been utilized for modeling anxiety in rodent novelty-based paradigms (e.g., open field, light–dark, and elevated plus maze tests, based on the balance between exploration and avoidance/neophobia) [90]. Aquatic ‘novelty’ tests, such as the novel tank, light– dark box, and open field tests, are conceptually similar to these rodent models and have been extensively validated in zebrafish [4]. Acute stress-based models (e.g., predator exposure or acute restraint) are also used in both rodent and zebrafish models of anxiety spectrum disorders (Table 2).
Finally, genetic models are becoming increasingly useful for anxiety research in zebrafish. For example, several zebrafish strains display higher baseline anxiety phenotype than other strains [7], and may therefore be relevant to generalized anxiety disorder and dissecting its neural underpinnings (Table 1), similar to the use of high/low-anxiety mouse strains [90]. Furthermore, a promising new genetic model of affective disorders, recently developed in zebrafish [24,25], is based on disrupted negative feedback on the stress response in glucocorticoid receptor (GR) knockout zebrafish. These mutants display elevated cortisol levels and higher stress responsivity associated with anxiety-like behavior (Table 2), which can be corrected by fluoxetine [24]. In addition, mutant zebrafish with reduced anxiety have also been developed. For example, zebrafish with a mutated fmr1 gene (encoding for the fragile X mental retardation 1 protein) display anxiolytic-like responses [91]. The latter two strains are important for bidirectional modulation of anxiety in zebrafish, potentially useful for both disease modeling and screening for novel anxiotropic drugs.
Concluding remarks: moving from tank to bedside
In summary, zebrafish represent an ideal organism for neurophenotyping, HTS, and brain imaging studies (Figures 1–4), which also facilitate in vivo drug discovery and genetic screening. Possessing high physiological and genetic homology to humans, zebrafish have become increasingly useful in studying a wide spectrum of human brain disorders, from brain cancer to epilepsy to complex affective disorders. Baseline data on normal and pathological behaviors or spontaneous and induced brain tissue pathology are becoming widely available in zebrafish, gradually approaching the knowledge base for other well-studied laboratory animals [7,13]. Although many biological problems remain to be addressed in zebrafish (Box 1), the availability of both a sensitive model organism and a growing set of experimental tools (e.g., Figure 4) is particularly timely. There are also several excellent public access biomedical databases available to zebrafish investigators working with neurogenetics, pharmacology, and brain imaging (see Box 1 for details).
Although there is currently a relatively small group of highly trained zebrafish neuroscientists and pathologists, the field is expanding rapidly [13]. We also expect the growing need in their expertise, as zebrafish models become important tools in today’s neuroscience research. At the same time, because zebrafish paradigms show many parallels with rodent and human phenotypes [7], it is equally important to not anthropomorphize zebrafish models and tests, and to be aware that the disorder-specific and species-specific issues may play an important role in our interpretation of zebrafish responses. Although human behavior will never be similar to fish responses (and vice versa), the evolutionarily conserved nature of complex CNS traits suggests that many human and zebrafish phenotypes share common genetic and physiological factors, representing an exciting emerging field for further translational studies in neuroscience [7,13,20,97,120].
Supplementary Material
Acknowledgments
The authors thank Dr Jeremy Ullmann (University of Queensland, Australia), as well as Dr Lucas Noldus, Ruud Tegelenbosch and colleagues (Noldus IT, The Netherlands) for supplying images for Figures 2A and 3A, and D of this paper, and assistance in addressing reviewer’s comments. The authors acknowledge the Croll and Fine laboratories (Dalhousie University, Canada) for providing the brain images for Figure 2B and C, and Mr Michael Nguyen for his assistance with this manuscript. We also thank members of the Kalueff (ZENEREI Institute, USA) and the Spitsbergen (Oregon State University, USA) laboratories for collecting samples and images used in this study. This research is supported by the National Institutes of Health/National Institute on Drug Abuse (NIH/NIDA) (A.V.K.), as well as by the NIH/National Institute on Alcohol Abuse and Alcoholism (NIAAA) and the Natural Sciences and Engineering Research Council of Canada (NSERC) (R.G.).
Glossary
- Altered early proto-oncogene expression
analyses of the CNS expression of early proto-oncogenes (e.g., c-fos), a useful tool in zebrafish neuroscience. Activation of c-fos expression in the whole brain samples is frequently seen in zebrafish following pro-excitatory pharmacological modulation (e.g., by convulsant agents, Figure 3, or by selected psychostimulants and hallucinogens [27,48,111]). c-fos expression can also serve as a marker of neuronal activation, and is assessed more specifically in different brain regions, therefore providing functional mapping of brain activity in response to various acute or chronic challenges (see section on zebrafish circuitry for examples). Brain c-fos can be upregulated in zebrafish following exposure to alarm pheromone, predators, and/or novelty stress.
- Behavioral phenomics
an emerging field of neuroscience that integrates multidisciplinary behavioral, physiological, and genomics research, aiming to understand the complex phenotypic consequences of genetic mutations and environmental manipulations [58] at the level of the organism (such as zebrafish). An important goal of zebrafish behavioral phenomics is to increase the ability to measure and dissect various phenotypes (e.g., by using HTS and test batteries).
- Endocrine stress responses
zebrafish possess a well-developed neuroendocrine system, generally highly homologous to that in mammals [7,112]. The zebrafish stress neuroendocrine (hypothalamo–pituitary–inter-renal, HPI) axis is similar to the human and rodent hypothalamo–pituitary–adrenal (HPA) axis, and releases cortisol following stress exposure (Figure 1C). Zebrafish cortisol responses generally correlate with behavioral indices of stress, and may be modulated experimentally (e.g., genetically or pharmacologically, Table 1) [24,25,94,107]. Methods to assess cortisol in zebrafish (including both adult [94] and larval [113] fish) include ELISA or radioligand binding assays using whole body, blood samples, and/or urine-containing water samples, where applicable.
- Genetic tools
the zebrafish has been successfully utilized in ‘forward genetics’ (FG), an approach that includes the generation of random mutations (typically using chemical mutagens, such as ethylnitrosourea, ENU), with subsequent screening for phenotypical alterations [7]. FG aims to identify, based on the detected altered phenotype, novel genes whose protein products play roles in the phenotype of interest. ENU has allowed researchers to generate a large number of zebrafish mutants, and screening such mutants yielded important discoveries about the mechanisms of embryonic development, as well as larval and adult behavior and brain function. However, ENU-based FG studies require laborintensive linkage analysis-based positional cloning to identify the mutated gene. New alternative methods, including viral vector-based insertional mutagenesis or gene breaking transposon-based mutagenesis, have now been developed, enabling the identification of genes involved in neurobehavioral phenotypes more efficiently [7]. The goal of ‘reverse genetics’ (RG) is to characterize the function of known genes. Although mouse homologous recombination-based gene targeting using embryonic stem cells is a powerful RG method, it is not feasible for the zebrafish. Nevertheless, new technologies may revolutionize gene targeting as they enable more efficient targeted mutation of genes in zebrafish. One such method is the transcription activator-like effector nuclease (TALEN) technology that utilizes custom-designed artificial restriction endonuclease-like enzymes cutting at user-defined nucleotide sequences, specific to the target gene. Other RG approaches, successfully validated in zebrafish, include the morpholino knockdown and the ‘targeting induced local lesions in genomes’ (TILLING) system [7].
Footnotes
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in the online version, at doi:10.1016/j.tins.2014.02.011.
References
- 1.Parker MO, et al. Development and automation of a test of impulse control in zebrafish. Front. Syst. Neurosci. 2013;7:65. doi: 10.3389/fnsys.2013.00065. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Collier AD, Echevarria DJ. The utility of the zebrafish model in conditioned place preference to assess the rewarding effects of drugs. Behav. Pharmacol. 2013;24:375–383. doi: 10.1097/FBP.0b013e328363d14a. [DOI] [PubMed] [Google Scholar]
- 3.Stewart AM, et al. Perspectives of zebrafish models of epilepsy: what, how and where next? Brain Res. Bull. 2012;87:135–143. doi: 10.1016/j.brainresbull.2011.11.020. [DOI] [PubMed] [Google Scholar]
- 4.Stewart A, et al. Modeling anxiety using adult zebrafish: a conceptual review. Neuropharmacology. 2012;62:135–143. doi: 10.1016/j.neuropharm.2011.07.037. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Grossman L, et al. Characterization of behavioral and endocrine effects of LSD on zebrafish. Behav. Brain Res. 2010;214:277–284. doi: 10.1016/j.bbr.2010.05.039. [DOI] [PubMed] [Google Scholar]
- 6.Cachat J, et al. Measuring behavioral and endocrine responses to novelty stress in adult zebrafish. Nat. Protoc. 2010;5:1786–1799. doi: 10.1038/nprot.2010.140. [DOI] [PubMed] [Google Scholar]
- 7.Kalueff AV, et al. Zebrafish as an emerging model for studying complex brain disorders. Trends Pharmacol. Sci. 2014;35:63–75. doi: 10.1016/j.tips.2013.12.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Ablain J, Zon LI. Of fish and men: using zebrafish to fight human diseases. Trends Cell Biol. 2013;23:584–586. doi: 10.1016/j.tcb.2013.09.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Brennan CH. Zebrafish behavioural assays of translational relevance for the study of psychiatric disease. Rev. Neurosci. 2011;22:37–48. doi: 10.1515/RNS.2011.006. [DOI] [PubMed] [Google Scholar]
- 10.Steenbergen PJ, et al. The use of the zebrafish model in stress research. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2011;35:1432–1451. doi: 10.1016/j.pnpbp.2010.10.010. [DOI] [PubMed] [Google Scholar]
- 11.Gerlai R. Using zebrafish to unravel the genetics of complex brain disorders. Curr. Top. Behav. Neurosci. 2012;12:3–24. doi: 10.1007/7854_2011_180. [DOI] [PubMed] [Google Scholar]
- 12.Ahmad F, et al. Zebrafish embryos and larvae in behavioural assays. Behavior. 2012;149:1241–1281. [Google Scholar]
- 13.Kalueff AV, et al. Gaining translational momentum: more zebrafish models for neuroscience research. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2014 doi: 10.1016/j.pnpbp.2014.01.022. http://dx.doi.org/10.1016/j.pnpbp.2014.01.022. [DOI] [PubMed]
- 14.Miller N, et al. Effects of nicotine and alcohol on zebrafish (Danio rerio) shoaling. Behav. Brain Res. 2013;240:192–196. doi: 10.1016/j.bbr.2012.11.033. [DOI] [PubMed] [Google Scholar]
- 15.Drew RE, et al. Brain transcriptome variation among behaviorally distinct strains of zebrafish (Danio rerio) BMC Genomics. 2012;13:323. doi: 10.1186/1471-2164-13-323. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Pippal JB, et al. Characterization of the zebrafish (Danio rerio) mineralocorticoid receptor. Mol. Cell. Endocrinol. 2011;332:58–66. doi: 10.1016/j.mce.2010.09.014. [DOI] [PubMed] [Google Scholar]
- 17.Buske C, Gerlai R. Early embryonic ethanol exposure impairs shoaling and the dopaminergic and serotoninergic systems in adult zebrafish. Neurotoxicol. Teratol. 2011;33:698–707. doi: 10.1016/j.ntt.2011.05.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Buske C, Gerlai R. Shoaling develops with age in zebrafish (Danio rerio) Prog. Neuropsychopharmacol. Biol. Psychiatry. 2011;35:1409–1415. doi: 10.1016/j.pnpbp.2010.09.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Kalueff AV, et al. Towards a comprehensive catalog of zebrafish behavior 1.0 and beyond. Zebrafish. 2013;10:70–86. doi: 10.1089/zeb.2012.0861. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Gerlai R. Zebrafish antipredatory responses: a future for translational research? Behav. Brain Res. 2010;207:223–231. doi: 10.1016/j.bbr.2009.10.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Stewart AM, et al. Developing zebrafish models of autism spectrum disorder (ASD) Prog. Neuropsychopharmacol. Biol. Psychiatry. 2014;50C:27–36. doi: 10.1016/j.pnpbp.2013.11.014. [DOI] [PubMed] [Google Scholar]
- 22.López Patiño MA, et al. Gender differences in zebrafish responses to cocaine withdrawal. Physiol. Behav. 2008;95:36–47. doi: 10.1016/j.physbeh.2008.03.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Singh A, et al. Involvement of the α1-adrenoceptor in sleep-waking and sleep loss-induced anxiety behavior in zebrafish. Neuroscience. 2013;245:136–147. doi: 10.1016/j.neuroscience.2013.04.026. [DOI] [PubMed] [Google Scholar]
- 24.Ziv L, et al. An affective disorder in zebrafish with mutation of the glucocorticoid receptor. Mol. Psychiatry. 2013;18:681–691. doi: 10.1038/mp.2012.64. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Griffiths BB, et al. A zebrafish model of glucocorticoid resistance shows serotonergic modulation of the stress response. Front. Behav. Neurosci. 2012;6:68. doi: 10.3389/fnbeh.2012.00068. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Parker MO, et al. Discrimination reversal and attentional sets in zebrafish (Danio rerio) Behav. Brain Res. 2012;232:264–268. doi: 10.1016/j.bbr.2012.04.035. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Cachat J, et al. Unique and potent effects of acute ibogaine on zebrafish: the developing utility of novel aquatic models for hallucinogenic drug research. Behav. Brain Res. 2013;236:258–269. doi: 10.1016/j.bbr.2012.08.041. [DOI] [PubMed] [Google Scholar]
- 28.Neelkantan N, et al. Perspectives on zebrafish models of hallucinogenic drugs and related psychotropic compounds. ACS Chem. Neurosci. 2013;4:1137–1150. doi: 10.1021/cn400090q. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Kyzar EJ, et al. Effects of hallucinogenic agents mescaline and phencyclidine on zebrafish behavior and physiology. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2012;37:194–202. doi: 10.1016/j.pnpbp.2012.01.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Stewart AM, Kalueff AV. Developing better and more valid animal models of brain disorders. Behav. Brain Res. 2013 doi: 10.1016/j.bbr.2013.12.024. http://dx.doi.org/10.1016/j.bbr.2013.12.024. [DOI] [PubMed]
- 31.Panier T, et al. Fast functional imaging of multiple brain regions in intact zebrafish larvae using selective plane illumination microscopy. Front. Neural Circuits. 2013;7:65. doi: 10.3389/fncir.2013.00065. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Ahrens MB, et al. Whole-brain functional imaging at cellular resolution using light-sheet microscopy. Nat. Methods. 2013;10:413–420. doi: 10.1038/nmeth.2434. [DOI] [PubMed] [Google Scholar]
- 33.White RM, et al. Transparent adult zebrafish as a tool for in vivo transplantation analysis. Cell Stem Cell. 2008;2:183–189. doi: 10.1016/j.stem.2007.11.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Wenner M. The most transparent research. Nat. Med. 2009;15:1106–1109. doi: 10.1038/nm1009-1106. [DOI] [PubMed] [Google Scholar]
- 35.Ullmann JF, et al. A three-dimensional digital atlas of the zebrafish brain. Neuroimage. 2010;51:76–82. doi: 10.1016/j.neuroimage.2010.01.086. [DOI] [PubMed] [Google Scholar]
- 36.Braubach OR, et al. Distribution and functional organization of glomeruli in the olfactory bulbs of zebrafish (Danio rerio) J. Comp. Neurol. 2012;520:2317–2339. doi: 10.1002/cne.23075. [DOI] [PubMed] [Google Scholar]
- 37.Kaslin J, Panula P. Comparative anatomy of the histaminergic and other aminergic systems in zebrafish (Danio rerio) J. Comp. Neurol. 2001;440:342–377. doi: 10.1002/cne.1390. [DOI] [PubMed] [Google Scholar]
- 38.Morley BJ, Mervis RF. Dendritic spine alterations in the hippocampus and parietal cortex of α7 nicotinic acetylcholine receptor knockout mice. Neuroscience. 2013;233:54–63. doi: 10.1016/j.neuroscience.2012.12.025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Kerr JN, Denk W. Imaging in vivo: watching the brain in action. Nat. Rev. Neurosci. 2008;9:195–205. doi: 10.1038/nrn2338. [DOI] [PubMed] [Google Scholar]
- 40.Ljunggren EE, et al. Optogenetic activation of excitatory premotor interneurons is sufficient to generate coordinated locomotor activity in larval zebrafish. J. Neurosci. 2014;34:134–139. doi: 10.1523/JNEUROSCI.4087-13.2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.De Marco RJ, et al. Optogenetic elevation of endogenous glucocorticoid level in larval zebrafish. Front. Neural Circuits. 2013;7:82. doi: 10.3389/fncir.2013.00082. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Portugues R, et al. Optogenetics in a transparent animal: circuit function in the larval zebrafish. Curr. Opin. Neurobiol. 2013;23:119–126. doi: 10.1016/j.conb.2012.11.001. [DOI] [PubMed] [Google Scholar]
- 43.Zhu P, et al. Optogenetic dissection of neuronal circuits in zebrafish using viral gene transfer and the Tet system. Front. Neural Circuits. 2009;3:21. doi: 10.3389/neuro.04.021.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Ke MT, et al. SeeDB: a simple and morphology-preserving optical clearing agent for neuronal circuit reconstruction. Nat. Neurosci. 2013;16:1154–1161. doi: 10.1038/nn.3447. [DOI] [PubMed] [Google Scholar]
- 45.Chung K, Deisseroth K. CLARITY for mapping the nervous system. Nat. Methods. 2013;10:508–513. doi: 10.1038/nmeth.2481. [DOI] [PubMed] [Google Scholar]
- 46.Akerboom J, et al. Genetically encoded calcium indicators for multi-color neural activity imaging and combination with optogenetics. Front. Mol. Neurosci. 2013;6:2. doi: 10.3389/fnmol.2013.00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Dreosti E, et al. A genetically encoded reporter of synaptic activity in vivo. Nat. Methods. 2009;6:883–889. doi: 10.1038/nmeth.1399. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Green J, et al. Automated high-throughput neurophenotyping of zebrafish social behavior. J. Neurosci. Methods. 2012;210:266–271. doi: 10.1016/j.jneumeth.2012.07.017. [DOI] [PubMed] [Google Scholar]
- 49.Pittman JT, Ichikawa KM. iPhone(R) applications as versatile video tracking tools to analyze behavior in zebrafish (Danio rerio) Pharmacol. Biochem. Behav. 2013;106:137–142. doi: 10.1016/j.pbb.2013.03.013. [DOI] [PubMed] [Google Scholar]
- 50.Cachat J, et al. Three-dimensional neurophenotyping of adult zebrafish behavior. PLoS ONE. 2011;6:e17597. doi: 10.1371/journal.pone.0017597. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Stewart A, et al. Pharmacological modulation of anxiety-like phenotypes in adult zebrafish behavioral models. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2011;35:1421–1431. doi: 10.1016/j.pnpbp.2010.11.035. [DOI] [PubMed] [Google Scholar]
- 52.Zafeiriou DI, et al. Autism spectrum disorders: the quest for genetic syndromes. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2013;162B:327–366. doi: 10.1002/ajmg.b.32152. [DOI] [PubMed] [Google Scholar]
- 53.Gerlai J, Gerlai R. Autism: a large unmet medical need and a complex research problem. Physiol. Behav. 2003;79:461–470. doi: 10.1016/s0031-9384(03)00165-3. [DOI] [PubMed] [Google Scholar]
- 54.Maaswinkel H, et al. Assessing social engagement in heterogeneous groups of zebrafish: a new paradigm for autism-like behavioral responses. PLoS ONE. 2013;8:e75955. doi: 10.1371/journal.pone.0075955. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Minassian A, et al. Repeated assessment of exploration and novelty seeking in the human behavioral pattern monitor in bipolar disorder patients and healthy individuals. PLoS ONE. 2011;6:e24185. doi: 10.1371/journal.pone.0024185. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Young JW, et al. A reverse-translational approach to bipolar disorder: rodent and human studies in the behavioral pattern monitor. Neurosci. Biobehav. Rev. 2007;31:882–896. doi: 10.1016/j.neubiorev.2007.05.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Maaswinkel H, et al. Dissociating the effects of habituation, black walls, buspirone and ethanol on anxiety-like behavioral responses in shoaling zebrafish. A 3D approach to social behavior. Pharmacol. Biochem. Behav. 2013;108:16–27. doi: 10.1016/j.pbb.2013.04.009. [DOI] [PubMed] [Google Scholar]
- 58.Gerlai R. Phenomics: fiction or the future? Trends Neurosci. 2002;25:506–509. doi: 10.1016/s0166-2236(02)02250-6. [DOI] [PubMed] [Google Scholar]
- 59.Baraban SC, et al. Drug screening in Scn1a zebrafish mutant identifies clemizole as a potential Dravet syndrome treatment. Nat. Commun. 2013;4:2410. doi: 10.1038/ncomms3410. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Hortopan GA, Baraban SC. Aberrant expression of genes necessary for neuronal development and Notch signaling in an epileptic mind bomb zebrafish. Dev. Dyn. 2011;240:1964–1976. doi: 10.1002/dvdy.22680. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Hortopan GA, et al. Spontaneous seizures and altered gene expression in GABA signaling pathways in a mind bomb mutant zebrafish. J. Neurosci. 2010;30:13718–13728. doi: 10.1523/JNEUROSCI.1887-10.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Ellis LD, Soanes KH. A larval zebrafish model of bipolar disorder as a screening platform for neuro-therapeutics. Behav. Brain Res. 2012;233:450–457. doi: 10.1016/j.bbr.2012.05.043. [DOI] [PubMed] [Google Scholar]
- 63.Crawley JN. Behavioral phenotyping strategies for mutant mice. Neuron. 2008;57:809–818. doi: 10.1016/j.neuron.2008.03.001. [DOI] [PubMed] [Google Scholar]
- 64.Bailey KR, et al. Behavioral phenotyping of transgenic and knockout mice: practical concerns and potential pitfalls. ILAR J. 2006;47:124–131. doi: 10.1093/ilar.47.2.124. [DOI] [PubMed] [Google Scholar]
- 65.Crawley JN. Behavioral phenotyping of rodents. Comp. Med. 2003;53:140–146. [PubMed] [Google Scholar]
- 66.McIlwain KL, et al. The use of behavioral test batteries: effects of training history. Physiol. Behav. 2001;73:705–717. doi: 10.1016/s0031-9384(01)00528-5. [DOI] [PubMed] [Google Scholar]
- 67.Crawley JN, Paylor R. A proposed test battery and constellations of specific behavioral paradigms to investigate the behavioral phenotypes of transgenic and knockout mice. Horm. Behav. 1997;31:197–211. doi: 10.1006/hbeh.1997.1382. [DOI] [PubMed] [Google Scholar]
- 68.Wurbel H. Behavioral phenotyping enhanced – beyond (environmental) standardization. Genes Brain Behav. 2002;1:3–8. doi: 10.1046/j.1601-1848.2001.00006.x. [DOI] [PubMed] [Google Scholar]
- 69.Wahlsten D, et al. Different data from different labs: lessons from studies of gene–environment interaction. J. Neurobiol. 2003;54:283–311. doi: 10.1002/neu.10173. [DOI] [PubMed] [Google Scholar]
- 70.Crabbe JC, et al. Genetics of mouse behavior: interactions with laboratory environment. Science. 1999;284:1670–1672. doi: 10.1126/science.284.5420.1670. [DOI] [PubMed] [Google Scholar]
- 71.Kalueff AV, et al. What’s wrong with my mouse model? Advances and strategies in animal modeling of anxiety and depression. Behav. Brain Res. 2007;179:1–18. doi: 10.1016/j.bbr.2007.01.023. [DOI] [PubMed] [Google Scholar]
- 72.Okamoto H, Aizawa H. Fear and anxiety regulation by conserved affective circuits. Neuron. 2013;78:411–413. doi: 10.1016/j.neuron.2013.04.031. [DOI] [PubMed] [Google Scholar]
- 73.Insel TR. Mental Disorders as Circuit Disorders: Pointing the Way to New Treatments. The Dana Foundation; 2010. [Google Scholar]
- 74.Lau BY, et al. Identification of a brain center whose activity discriminates a choice behavior in zebrafish. Proc. Natl. Acad. Sci. U.S.A. 2011;108:2581–2586. doi: 10.1073/pnas.1018275108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Mathuru AS, Jesuthasan S. The medial habenula as a regulator of anxiety in adult zebrafish. Front. Neural Circuits. 2013;7:99. doi: 10.3389/fncir.2013.00099. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Agetsuma M, et al. The habenula is crucial for experience-dependent modification of fear responses in zebrafish. Nat. Neurosci. 2010;13:1354–1356. doi: 10.1038/nn.2654. [DOI] [PubMed] [Google Scholar]
- 77.White R, et al. Zebrafish cancer: the state of the art and the path forward. Nat. Rev. Cancer. 2013;13:624–636. doi: 10.1038/nrc3589. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Jing L, Zon LI. Zebrafish as a model for normal and malignant hematopoiesis. Dis. Model. Mech. 2011;4:433–438. doi: 10.1242/dmm.006791. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Spitsbergen JM, et al. Neoplasia and neoplasm-associated lesions in laboratory colonies of zebrafish emphasizing key influences of diet and aquaculture system design. ILAR J. 2012;53:114–125. doi: 10.1093/ilar.53.2.114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Ju B, et al. Co-activation of hedgehog and AKT pathways promote tumorigenesis in zebrafish. Mol. Cancer. 2009;8:40. doi: 10.1186/1476-4598-8-40. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Ceol CJ, et al. Melanoma biology and the promise of zebrafish. Zebrafish. 2008;5:247–255. doi: 10.1089/zeb.2008.0544. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Mussulini BH, et al. Seizures induced by pentylenetetrazole in the adult zebrafish: a detailed behavioral characterization. PLoS ONE. 2013;8:e54515. doi: 10.1371/journal.pone.0054515. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th edn. American Psychiatric Association; 2013. [Google Scholar]
- 84.Murphy JM. Trends in depression and anxiety: men and women. Acta Psychiatr. Scand. 1986;73:113–127. doi: 10.1111/j.1600-0447.1986.tb10576.x. [DOI] [PubMed] [Google Scholar]
- 85.Twenge JM. The age of anxiety? Birth cohort change in anxiety and neuroticism, 1952–1993. J. Pers. Soc. Psychol. 2000;79:1007–1021. doi: 10.1037//0022-3514.79.6.1007. [DOI] [PubMed] [Google Scholar]
- 86.Koenig HG, et al. Mental health care for older adults in the year 2020: a dangerous and avoided topic. Gerontologist. 1994;34:674–679. doi: 10.1093/geront/34.5.674. [DOI] [PubMed] [Google Scholar]
- 87.Stewart AM, Kalueff AV. Anxiolytic drug discovery: what are the novel approaches and how can we improve them? Expert Opin. Drug Discov. 2014;9:15–26. doi: 10.1517/17460441.2014.857309. [DOI] [PubMed] [Google Scholar]
- 88.McGonnell IM, Fowkes RC. Fishing for gene function – endocrine modelling in the zebrafish. J. Endocrinol. 2006;189:425–439. doi: 10.1677/joe.1.06683. [DOI] [PubMed] [Google Scholar]
- 89.Alsop D, Vijayan MM. Development of the corticosteroid stress axis and receptor expression in zebrafish. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008;294:R711–R719. doi: 10.1152/ajpregu.00671.2007. [DOI] [PubMed] [Google Scholar]
- 90.Cryan JF, Holmes A. The ascent of mouse: advances in modelling human depression and anxiety. Nat. Rev. Drug Discov. 2005;4:775–790. doi: 10.1038/nrd1825. [DOI] [PubMed] [Google Scholar]
- 91.Ng MC, et al. Behavioral and synaptic circuit features in a zebrafish model of fragile X syndrome. PLoS ONE. 2013;8:e51456. doi: 10.1371/journal.pone.0051456. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92.Spence R, et al. The behaviour and ecology of the zebrafish, Danio rerio. Biol. Rev. Camb. Philos. Soc. 2008;83:13–34. doi: 10.1111/j.1469-185X.2007.00030.x. [DOI] [PubMed] [Google Scholar]
- 93.Piato AL, et al. Unpredictable chronic stress model in zebrafish (Danio rerio): behavioral and physiological responses. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2011;35:561–567. doi: 10.1016/j.pnpbp.2010.12.018. [DOI] [PubMed] [Google Scholar]
- 94.Egan RJ, et al. Understanding behavioral and physiological phenotypes of stress and anxiety in zebrafish. Behav. Brain Res. 2009;205:38–44. doi: 10.1016/j.bbr.2009.06.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95.Okamoto H, et al. Genetic dissection of the zebrafish habenula, a possible switching board for selection of behavioral strategy to cope with fear and anxiety. Dev. Neurobiol. 2012;72:386–394. doi: 10.1002/dneu.20913. [DOI] [PubMed] [Google Scholar]
- 96.Blaser RE, Rosemberg DB. Measures of anxiety in zebrafish (Danio rerio): dissociation of black/white preference and novel tank test. PLoS ONE. 2012;7:e36931. doi: 10.1371/journal.pone.0036931. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97.Jesuthasan S. Fear, anxiety, and control in the zebrafish. Dev. Neurobiol. 2012;72:395–403. doi: 10.1002/dneu.20873. [DOI] [PubMed] [Google Scholar]
- 98.Blaser RE, et al. Behavioral measures of anxiety in zebrafish (Danio rerio) Behav. Brain Res. 2010;208:56–62. doi: 10.1016/j.bbr.2009.11.009. [DOI] [PubMed] [Google Scholar]
- 99.Maximino C, et al. Measuring anxiety in zebrafish: a critical review. Behav. Brain Res. 2010;214:157–171. doi: 10.1016/j.bbr.2010.05.031. [DOI] [PubMed] [Google Scholar]
- 100.Maximino C, et al. Parametric analyses of anxiety in zebrafish scototaxis. Behav. Brain Res. 2010;210:1–7. doi: 10.1016/j.bbr.2010.01.031. [DOI] [PubMed] [Google Scholar]
- 101.Blaser RE, Penalosa YM. Stimuli affecting zebrafish (Danio rerio) behavior in the light/dark preference test. Physiol. Behav. 2011;104:831–837. doi: 10.1016/j.physbeh.2011.07.029. [DOI] [PubMed] [Google Scholar]
- 102.Luca RM, Gerlai R. In search of optimal fear inducing stimuli: differential behavioral responses to computer animated images in zebrafish. Behav. Brain Res. 2012;226:66–76. doi: 10.1016/j.bbr.2011.09.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 103.Ahmed O, et al. An automated predator avoidance task in zebrafish. Behav. Brain Res. 2011;216:166–171. doi: 10.1016/j.bbr.2010.07.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 104.Cianca V, et al. A robotics-based behavioral paradigm to measure anxiety-related responses in zebrafish. PLoS ONE. 2013;8:e69661. doi: 10.1371/journal.pone.0069661. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 105.Luca RM, Gerlai R. Animated bird silhouette above the tank: acute alcohol diminishes fear responses in zebrafish. Behav. Brain Res. 2012;229:194–201. doi: 10.1016/j.bbr.2012.01.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 106.Speedie N, Gerlai R. Alarm substance induced behavioral responses in zebrafish (Danio rerio) Behav. Brain Res. 2008;188:168–177. doi: 10.1016/j.bbr.2007.10.031. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 107.Cachat J, et al. Modeling withdrawal syndrome in zebrafish. Behav. Brain Res. 2010;208:371–376. doi: 10.1016/j.bbr.2009.12.004. [DOI] [PubMed] [Google Scholar]
- 108.Maximino C, et al. Behavioral and neurochemical changes in the zebrafish leopard strain. Genes Brain Behav. 2013;12:576–582. doi: 10.1111/gbb.12047. [DOI] [PubMed] [Google Scholar]
- 109.Piato AL, et al. Acute restraint stress in zebrafish: behavioral parameters and purinergic signaling. Neurochem. Res. 2011;36:1876–1886. doi: 10.1007/s11064-011-0509-z. [DOI] [PubMed] [Google Scholar]
- 110.Kalueff AV, et al. Conserved role for the serotonin transporter gene in rat and mouse neurobehavioral endophenotypes. Neurosci. Biobehav. Rev. 2010;34:373–386. doi: 10.1016/j.neubiorev.2009.08.003. [DOI] [PubMed] [Google Scholar]
- 111.Riehl R, et al. Behavioral and physiological effects of acute ketamine exposure in adult zebrafish. Neurotoxicol. Teratol. 2011;33:658–667. doi: 10.1016/j.ntt.2011.05.011. [DOI] [PubMed] [Google Scholar]
- 112.Nguyen M, et al. Developing ‘integrative’ zebrafish models of behavioral and metabolic disorders. Behav. Brain Res. 2013;256:172–187. doi: 10.1016/j.bbr.2013.08.012. [DOI] [PubMed] [Google Scholar]
- 113.Yeh CM, et al. An optimized whole-body cortisol quantification method for assessing stress levels in larval zebrafish. PLoS ONE. 2013;8:e79406. doi: 10.1371/journal.pone.0079406. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 114.Crawley JN. Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests. Brain Res. 1999;835:18–26. doi: 10.1016/s0006-8993(98)01258-x. [DOI] [PubMed] [Google Scholar]
- 115.Kalueff AV, et al. Hybridizing behavioral models: a possible solution to some problems in neurophenotyping research? Prog. Neuropsychopharmacol. Biol. Psychiatry. 2008;32:1172–1178. doi: 10.1016/j.pnpbp.2007.12.010. [DOI] [PubMed] [Google Scholar]
- 116.Dahlbom SJ, et al. Aggression and monoamines: effects of sex and social rank in zebrafish (Danio rerio) Behav. Brain Res. 2012;228:333–338. doi: 10.1016/j.bbr.2011.12.011. [DOI] [PubMed] [Google Scholar]
- 117.Philpott C, et al. Reducing the noise in behavioral assays: sex and age in adult zebrafish locomotion. Zebrafish. 2012;9:191–194. doi: 10.1089/zeb.2012.0764. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 118.Tudorache C, et al. Covariation between behaviour and physiology indicators of coping style in zebrafish (Danio rerio) J. Endocrinol. 2013;219:251–258. doi: 10.1530/JOE-13-0225. [DOI] [PubMed] [Google Scholar]
- 119.Cruz SA, et al. Glucocorticoid receptor, but not mineralocorticoid receptor, mediates cortisol regulation of epidermal ionocyte development and ion transport in zebrafish (Danio rerio) PLoS ONE. 2013;8:e77997. doi: 10.1371/journal.pone.0077997. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 120.Portugues R, et al. Whole-brain activity maps reveal stereotyped, distributed networks for visuomotor behavior. Neuron. 2014;81:1328–1343. doi: 10.1016/j.neuron.2014.01.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.